Skip to main content
Log in

Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: A case-control study

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

The reduction of hospitalizations in patients with heart failure (HF) may have clinical and economical implications.

Materials and methods

In a case-control study, we compared the number of hospital admissions for congestive HF during the same follow-up period in two homogeneous groups of patients, each consisting of 27 consecutive patients treated with biventricular pacing and back-up defibrillator (B-ICD) in our institution. The first group was implanted with an InSync Sentry®, (Medtronic Inc, Minneapolis, MN, US), a B-ICD device with the OptiVol®feature for monitoring intrathoracic fluid accumulation and equipped with an active acoustic alarm (Group 1); the second group was implanted with an InSync III Marquis™(Medtronic), a B-ICD device with similar features except for the absence of the OptiVol (Group 2). Follow-up visits were performed at 3 month interval or in case of acoustic alarm.

Results

The patient clinical characteristics of the two groups were similar. In Group 1, with 359 ± 98 days follow-up, 12 of the 27 patients, experienced 18 OptiVol alarms with only one hospital admission for congestive HF occurring in a patient who ignored the acoustic alarm for 13 days. In Group 2, eight HF hospitalizations occurred in seven patients (p < 0.05).

Conclusions

The OptiVol feature is a useful tool for the clinical management of HF patients as it can result in early treatment during the pre-clinic stage of HF decompensation and in a significant reduction of hospital admissions for congestive HF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. The CONSENSUS Trial Study Group (1987). Effects of Enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New England Journal of Medicine, 316, 1429–1435.

    Article  Google Scholar 

  2. Pitt, B., Poole-Wilson, P. A., Segal, R., Martinez, F. A., Dickstein, K., Camm, A. J., et al. (2000). Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial—the Losartan Heart Failure Survival Study ELITE II. Lancet, 355, 1582–1587.

    Article  PubMed  CAS  Google Scholar 

  3. Bristow, M. R. (2000). Beta-adrenergic receptor blockade in chronic heart failure. Circulation, 101, 558–569.

    PubMed  CAS  Google Scholar 

  4. Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., et al. (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine, 341, 709–717.

    Article  PubMed  CAS  Google Scholar 

  5. The Digitalis Investigation group (1997). The effect of digoxin on mortality and morbidity in patients with heart failure. New England Journal of Medicine, 336, 525–533.

    Article  Google Scholar 

  6. Heart Failure Society of America (HFSA) (1999). HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacologic approaches. Journal of Cardiac Failure, 5, 357–382.

    Article  Google Scholar 

  7. Gras, D., Mabo, P., Tang, T., Luttikuis, O., Chatoor, R., Pedersen, A. K., et al. (1998). Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync Study. Pacing and Clinical Electrophysiology, 21, 2249–2255.

    Article  PubMed  CAS  Google Scholar 

  8. Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., et al. (2001). Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. New England Journal of Medicine, 344, 873–880.

    Article  PubMed  CAS  Google Scholar 

  9. Young, J. B., Abraham, W. T., Smith, A. L., Leon, A. R., Lieberman, R., Wilkoff, B., et al. (2003). Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. Journal of the American Medical Association, 289, 2685–2694.

    Article  PubMed  Google Scholar 

  10. Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350, 2140–2150.

    Article  PubMed  CAS  Google Scholar 

  11. Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539–1549.

    Article  PubMed  CAS  Google Scholar 

  12. Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., et al. (2006). Heart disease and stroke statistics—2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113, e85–e151.

    Article  PubMed  Google Scholar 

  13. O’Connell, J. B. (2000). The economic burden of heart failure. Clinical Cardiology, 23(Suppl 3), III6–III10.

    Article  PubMed  CAS  Google Scholar 

  14. Sackner-Bernstein, J. (2004). What is heart failure and what are the treatment options? Complex questions. In D. L. Hayes, P. J. Wang, J. Sackner-Bernstein, & S. J. Asirvatham (Eds.), Resynchronization and defibrillation for heart failure (pp. 1–2). Oxford, UK: Blackwell.

    Google Scholar 

  15. Wang, L., Lahatinen, S., Lentz, L., Rakow, N., Kaszas, C., Ruetz, L., et al. (2005). Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model. Pacing and Clinical Electrophysiology, 28, 404–411.

    Article  PubMed  Google Scholar 

  16. Yu, C. M., Wang, L., Chau, E., Chan, R. H., Kong, S. L., Tang, M. O., et al. (2005). Intrathoracic impedance monitoring in patients with heart failure. Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation, 112, 841–848.

    Article  PubMed  Google Scholar 

  17. Swedberg, K., Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., et al. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. European Heart Journal, 26, 1115–1140.

    Article  PubMed  CAS  Google Scholar 

  18. Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., et al. (2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Available at American College of Cardiology Web Site: http://www.acc.org/clinical/guidelines/failure/index.pdf

  19. McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971). The natural history of congestive heart failure: The Framingham study. New England Journal of Medicine, 285, 1441–1446.

    Article  PubMed  CAS  Google Scholar 

  20. Luepker, R. V., Michael, J. R., & Warbasse, J. R. (1973). Transthoracic electrical impedance: Quantitative evaluation of a non-invasive measure of thoracic fluid volume. American Heart Journal, 65, 83–93.

    Article  Google Scholar 

  21. Baker, L. E., & Danniston, J. C. (1974). Noninvasive measurement of intrathoracic fluids. Chest, 65(Suppl), 35S–37S.

    PubMed  Google Scholar 

  22. Sahalos, J. N., Nicolaidis, A., & Gotsis, N. (1986). The electrical impedance of the human thorax as a guide in evaluation of intrathoracic fluid volume? Physics in Medicine & Biology, 31, 425–439.

    Article  CAS  Google Scholar 

  23. Van de Water, J. M., Moumt, B. E., Barela, J. R., Schuster, R., & Leacook, F. S. (1973). Monitoring the chest with impedance. Chest, 64, 597–603.

    PubMed  Google Scholar 

  24. Jonsson, F., Madsen, P., Jorgensen, L. G., Lunding, M., & Secher, N. H. (1995). Thoracic electrical impedance and fluid balance during aortic surgery. Acta Anaesthesiologica Scandinavica, 39, 513–517.

    PubMed  CAS  Google Scholar 

  25. Perko, G., Perko, M., Jansen, E., & Secher, N. H. (1991). Thoracic impedance as an index of body fluid imbalance during cardiac surgery. Acta Anaesthesiologica Scandinavica, 35, 368–571.

    Article  Google Scholar 

  26. Jain, P., Massie, B. M., Gattis, W. A., Klein, L., & Gheorghiade, M. (2003). Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. American Heart Journal, 145, S3–S17.

    Article  PubMed  Google Scholar 

  27. Vollmann, D., Nagele, H., Schauerte, P., Wiegand, U., Butter, C., Zanotto, G., et al. (2007). Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. European Heart Journal, Feb 19.

  28. Ypenburg, C., Bax, J. J., van der Wall, E., Schalij, M. J., & van Erven, L. (2007). Intrathoracic impedance monitoring to predict decompensated heart failure. American Journal of Cardiology, 99, 554–557

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimiliano Maines.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maines, M., Catanzariti, D., Cemin, C. et al. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: A case-control study. J Interv Card Electrophysiol 19, 201–207 (2007). https://doi.org/10.1007/s10840-007-9155-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-007-9155-4

Keywords

Navigation